September 13, 2018: The US Patent Office has issued U.S. Patent No. 10,064,616 ( entitled “VARIABLE STIFFNESS SUTURE BRIDGES COMPATIBLE WITH VARIOUS SUTURE PATTERNS” to SUTUREGARD™ Medical, Inc.

March 30, 2018: Dan Ladizinsky, MD assumes CEO position at SUTUREGARD™ Medical .

March 27, 2018: Effective immediately, JULIVA™ Technologies Inc will go by the name “SUTUREGARD™ Medical” operating under JULVIA™ Technologies Inc. The move to a new name was a branding decision. SUTUREGARD™ is a more intuitive reference to our product line-up. 

March 20, 2018: SUTUREGARD™Medical publishes pre-clinical study demonstrating effectiveness of SUTUEGARD™ device in Advances in Wound Care

December 7, 2017: JULVIA™ Technologies Inc wins Pitch Oregon, seed stage competition.

November 15, 2017: OSU Venture Development Fund invests in JULVIA™ Technologies Inc.

Jen Akeroyd, PhD, RN, CEO/CoFounder  of JULVA™ Technologies Inc was named 2017 Entrepreneur of the Year by the Regional Accelerator and Innovation Network program.

JULVIA Technologies Inc research published in Journal of the Dermatology Nurses' Association showing the common prevalence of ingrowth of nonabsorbable sutures in dermatology.

JULVIA™ Technologies Inc research published in Journal of the Mechanical Behavior of Biomedical Materials showing deep sutures less effective than widely believed.  

JULVIA™ Technologies Inc Wins Business Oregon Grant

JULVIA™ Technologies Inc Wins Synapse MedTech Pitch Competition